Gene therapy rescues cilia defects and restores olfactory function in a mammalian ciliopathy model
- 2 September 2012
- journal article
- research article
- Published by Springer Science and Business Media LLC in Nature Medicine
- Vol. 18 (9), 1423-1428
- https://doi.org/10.1038/nm.2860
Abstract
Ciliopathies are caused by alterations in the development and function of cilia. Now Jeffrey Martens and his colleagues demonstrate anatomic and functional rescue of cilia development in mature, differentiated neurons by adenovirus-mediated restoration of expression of the wild-type protein intraflagellar transport protein 88 (Ift88) and show restoration of olfactory function in a mouse model of ciliopathy. A loss-of-function mutation in IFT88 is also identified in individuals with ciliopathies. Cilia are evolutionarily conserved microtubule-based organelles that are crucial for diverse biological functions, including motility, cell signaling and sensory perception1. In humans, alterations in the formation and function of cilia manifest clinically as ciliopathies, a growing class of pleiotropic genetic disorders2,3,4. Despite the substantial progress that has been made in identifying genes that cause ciliopathies, therapies for these disorders are not yet available to patients. Although mice with a hypomorphic mutation in the intraflagellar transport protein IFT88 (Ift88Tg737Rpw mice, also known as ORPK mice)5 have been well studied, the relevance of IFT88 mutations to human pathology is unknown. We show that a mutation in IFT88 causes a hitherto unknown human ciliopathy. In vivo complementation assays in zebrafish and mIMCD3 cells show the pathogenicity of this newly discovered allele. We further show that ORPK mice are functionally anosmic as a result of the loss of cilia on their olfactory sensory neurons (OSNs). Notably, adenoviral-mediated expression of IFT88 in mature, fully differentiated OSNs of ORPK mice is sufficient to restore ciliary structures and rescue olfactory function. These studies are the first to use in vivo therapeutic treatment to reestablish cilia in a mammalian ciliopathy. More broadly, our studies indicate that gene therapy is a viable option for cellular and functional rescue of the complex ciliary organelle in established differentiated cells.Keywords
This publication has 42 references indexed in Scilit:
- Ciliopathies with Skeletal Anomalies and Renal Insufficiency due to Mutations in the IFT-A Gene WDR19American Journal of Human Genetics, 2011
- TTC21B contributes both causal and modifying alleles across the ciliopathy spectrumNature Genetics, 2011
- Exome Sequencing Identifies WDR35 Variants Involved in Sensenbrenner SyndromeAmerican Journal of Human Genetics, 2010
- Cranioectodermal Dysplasia, Sensenbrenner Syndrome, Is a Ciliopathy Caused by Mutations in the IFT122 GeneAmerican Journal of Human Genetics, 2010
- Mutations in TMEM216 perturb ciliogenesis and cause Joubert, Meckel and related syndromesNature Genetics, 2010
- Odor-evoked gene regulation and visualization in olfactory receptor neuronsMolecular and Cellular Neuroscience, 2010
- The primary cilium as a cellular signaling center: lessons from diseaseCurrent Opinion in Genetics & Development, 2009
- A common allele in RPGRIP1L is a modifier of retinal degeneration in ciliopathiesNature Genetics, 2009
- Ciliary Abnormalities Due to Defects in the Retrograde Transport Protein DYNC2H1 in Short-Rib Polydactyly SyndromeAmerican Journal of Human Genetics, 2009
- The Oak Ridge Polycystic Kidney mouse: Modeling ciliopathies of mice and menDevelopmental Dynamics, 2008